Cargando…

Application of pseudotyped virus particles to monitor Ebola virus and SARS-CoV-2 viral entry in human cell lines

Experimental work on highly pathogenic viruses such as Ebola virus (EBOV) and severe acute respiratory syndrome coronavirus-2 requires high-level biosafety facilities. Here, we provide a detailed step-by-step protocol which details the production and application of replication-incompetent murine leu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eichler, Madeleine, Aksi, Ebru, Pfeilschifter, Josef, Imre, Gergely
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390363/ https://www.ncbi.nlm.nih.gov/pubmed/34467222 http://dx.doi.org/10.1016/j.xpro.2021.100818

Ejemplares similares

The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infection
por: Imre, Gergely, et al.
Publicado: (2021)

Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human Macrophages
por: Stantchev, Tzanko S., et al.
Publicado: (2019)

Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay
por: Urbanowicz, Richard A., et al.
Publicado: (2016)

Pseudotyped Vesicular Stomatitis Virus for Analysis of Virus Entry Mediated by SARS Coronavirus Spike Proteins
por: Fukushi, Shuetsu, et al.
Publicado: (2007)

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
por: Steeds, Kimberley, et al.
Publicado: (2020)

Analyses of Entry Mechanisms of Novel Emerging Viruses Using Pseudotype VSV System
por: Tani, Hideki
Publicado: (2014)

Analysis of Ebola Virus Entry Into Macrophages
por: Dahlmann, Franziska, et al.
Publicado: (2015)

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
por: Condor Capcha, Jose Manuel, et al.
Publicado: (2021)

N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry
por: Kononova, A. A., et al.
Publicado: (2017)

Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry
por: Lin, Han-Xin, et al.
Publicado: (2011)

Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
por: Bentley, Emma M., et al.
Publicado: (2021)

Reliability of Pseudotyped Influenza Viral Particles in Neutralizing Antibody Detection
por: Yang, Jinghui, et al.
Publicado: (2014)

Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system
por: Suda, Yuto, et al.
Publicado: (2016)

Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments
por: Stewart, Corina M., et al.
Publicado: (2021)

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
por: Crawford, Katharine H. D., et al.
Publicado: (2020)

Differences in Viral RNA Synthesis but Not Budding or Entry Contribute to the In Vitro Attenuation of Reston Virus Compared to Ebola Virus
por: Bodmer, Bianca S., et al.
Publicado: (2020)

Identification of SARS-CoV-2 viral entry inhibitors using machine learning and cell-based pseudotyped particle assay
por: Sun, Hongmao, et al.
Publicado: (2021)

An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells
por: Vamva, Eirini, et al.
Publicado: (2022)

Chemical and Structural Aspects of Ebola Virus Entry Inhibitors
por: Nyakatura, Elisabeth K., et al.
Publicado: (2014)

HER2-mediated enhancement of Ebola virus entry
por: Kuroda, Makoto, et al.
Publicado: (2020)

Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
por: Moeschler, Sarah, et al.
Publicado: (2016)

A descriptive guide for absolute quantification of produced shRNA pseudotyped lentiviral particles by real-time PCR
por: Mournetas, Virginie, et al.
Publicado: (2016)

Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles
por: Hsieh, Miao-Hsi, et al.
Publicado: (2021)

A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses
por: Saito, Takeshi, et al.
Publicado: (2020)

Cryo-EM analysis of Ebola virus nucleocapsid-like assembly
por: Wang, Yan, et al.
Publicado: (2021)

The use of pseudotypes to study viruses, virus sero-epidemiology and vaccination()
por: Bentley, Emma M., et al.
Publicado: (2015)

Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis
por: Ferrara, Francesca, et al.
Publicado: (2018)

A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry
por: Fels, J. Maximilian, et al.
Publicado: (2019)

Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein
por: Xiao, Julie Huiyuan, et al.
Publicado: (2018)

Ebola Virus Entry: A Curious and Complex Series of Events
por: Moller-Tank, Sven, et al.
Publicado: (2015)

Ebola Virus Entry into Host Cells: Identifying Therapeutic Strategies
por: Rhein, Bethany A., et al.
Publicado: (2015)

Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus
por: Cui, Qinghua, et al.
Publicado: (2018)

Ebola Virus Entry: From Molecular Characterization to Drug Discovery
por: Salata, Cristiano, et al.
Publicado: (2019)

Viral genomics in Ebola virus research
por: Di Paola, Nicholas, et al.
Publicado: (2020)

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2021)

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2022)

Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry
por: Yang, Shu, et al.
Publicado: (2018)

Effect of pseudotype on Abelson virus and Kirsten sarcoma virus-induced leukemia
Publicado: (1978)

The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus
por: Scott, Simon D., et al.
Publicado: (2016)

Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry
por: Long, Jason, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nq01fcdsdu1bggpf19sqj0oe5u